IMAX
Imax Corp
$
26.850
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
28.680
Open
28.570
VWAP
27.06
Vol
3.42M
Mkt Cap
1.44B
Low
26.670
Amount
92.66M
EV/EBITDA(TTM)
13.50
Total Shares
52.62M
EV
1.70B
EV/OCF(TTM)
22.06
P/S(TTM)
4.05
Imax Corporation is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium, architecture, patented intellectual property, and specialized equipment, the Company offers an end-to-end solution to create content experiences. The Company operates through two segments: Content Solutions and Technology Products and Services. The Content Solutions segment principally includes content enhancement and distribution services. This segment is also engaged in the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with artists and creators, as well as film post-production services. The Technology Products and Services principally includes the sale, lease, and maintenance of IMAX Systems. This segment is also involved in certain ancillary theater business activities, including after-market sales of IMAX System parts and three-dimensional (3D) glasses.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
98.86M
+8.1%
0.358
+2.38%
126.09M
+36.06%
0.519
+92.06%
91.32M
+5.37%
0.261
+100.71%
Estimates Revision
The market is revising No Change the revenue expectations for IMAX Corporation (IMAX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 12.06%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+6.17%
In Past 3 Month
Stock Price
Go Up
+12.06%
In Past 3 Month
9 Analyst Rating
21.27% Upside
Wall Street analysts forecast IMAX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMAX is 32.56 USD with a low forecast of 26.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
1 Hold
0 Sell
Strong Buy
21.27% Upside
Current: 26.850
Low
26.00
Averages
32.56
High
36.00
21.27% Upside
Current: 26.850
Low
26.00
Averages
32.56
High
36.00
Rosenblatt
Rosenblatt
Buy
maintain
$35 -> $37
2025-07-25
New
Reason
Rosenblatt
Rosenblatt
Price Target
$35 -> $37
2025-07-25
New
maintain
Buy
Reason
Rosenblatt raised the firm's price target on Imax to $37 from $35 and keeps a Buy rating on the shares. The firm is "pounding the table" on the shares after the company reported another quarter of upside. The shares are not pricing in Imax's growing market share, the strength of the film slate over the next few years and the potential for additional margin expansion as the box office grows.
Seaport Research
David Joyce
maintain
$31 -> $38
2025-07-25
New
Reason
Seaport Research
David Joyce
Price Target
$31 -> $38
2025-07-25
New
maintain
Reason
Seaport Research analyst David Joyce raised the firm's price target on Imax to $38 from $31 and keeps a Buy rating on the shares. The firm raised its price target on the stick given margin and multiple expansion heading into FY26, the analyst tells investors.
Goldman Sachs
Sell
maintain
$17 -> $18
2025-07-25
New
Reason
Goldman Sachs
Price Target
$17 -> $18
2025-07-25
New
maintain
Sell
Reason
Goldman Sachs raised the firm's price target on Imax to $18 from $17 and keeps a Sell rating on the shares. The firm notes the company reported Q2 results that were inline with consensus on Revenue and slightly above on company reported Adjusted EBITDA driven by operating leverage on higher revenues and continued execution against cost efficiencies.
Benchmark
Mike Hickey
Buy
maintain
$30 -> $32
2025-07-24
New
Reason
Benchmark
Mike Hickey
Price Target
$30 -> $32
2025-07-24
New
maintain
Buy
Reason
Benchmark analyst Mike Hickey raised the firm's price target on Imax to $32 from $30 and keeps a Buy rating on the shares following a "strong" Q2. The company posted a record Q2 North American box office of $143M and grew global box office 41% to $281.1M, driving global market share to 3.6% on less than 1% of screens. Imax's investment case is anchored by structural tailwinds in premium theatrical experiences, margin-rich system sales, and increasing adoption of Filmed for Imax content by studios, Benchmark told investors in a research note. The firm added that it is transitioning its valuation period from FY25 to a blended, normalized FY25/FY26 outlook.
Roth Capital
Eric Handler
Buy
maintain
$32 -> $36
2025-06-13
Reason
Roth Capital
Eric Handler
Price Target
$32 -> $36
2025-06-13
maintain
Buy
Reason
Roth Capital analyst Eric Handler raised the firm's price target on Imax to $36 from $32 and keeps a Buy rating on the shares after hosting talks with its senior management. IMAX's global box office is seeing a sizable resurgence and is on track to meet or beat 2025 guidance of $1.2B, while the company's market share is rising with improved utilization, the analyst tells investors in a research note. Theatre operator demand for new systems also remains robust, particularly in markets with above average revenue per screen, Roth added.
B. Riley
Drew Crum
Buy
maintain
$33 -> $36
2025-05-16
Reason
B. Riley
Drew Crum
Price Target
$33 -> $36
2025-05-16
maintain
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Imax Corp (IMAX.N) is 19.89, compared to its 5-year average forward P/E of 30.36. For a more detailed relative valuation and DCF analysis to assess Imax Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
30.36
Current PE
19.89
Overvalued PE
80.40
Undervalued PE
-19.68
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.87
Current EV/EBITDA
10.73
Overvalued EV/EBITDA
65.45
Undervalued EV/EBITDA
-63.71
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
3.20
Current PS
3.69
Overvalued PS
4.07
Undervalued PS
2.34
Financials
Annual
Quarterly
FY2025Q2
YoY :
+3.06%
91.68M
Total Revenue
FY2025Q2
YoY :
+396.70%
15.95M
Operating Profit
FY2025Q2
YoY :
+141.18%
12.24M
Net Income after Tax
FY2025Q2
YoY :
+185.71%
0.20
EPS - Diluted
FY2025Q2
YoY :
-41.21%
18.73M
Free Cash Flow
FY2025Q2
YoY :
+17.96%
56.49
Gross Profit Margin - %
FY2025Q2
YoY :
+42.50%
16.16
FCF Margin - %
FY2025Q2
YoY :
+134.04%
13.34
Net Margin - %
FY2025Q2
YoY :
+28.90%
5.53
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 339.72% over the last month.
Sold
0-3
Months
2.7M
USD
1
3-6
Months
616.6K
USD
1
6-9
Months
2.7M
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
40.0K
Volume
1
6-9
Months
320.6K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 339.72% over the last month.
Sold
0-3
Months
2.7M
USD
1
3-6
Months
616.6K
USD
1
6-9
Months
2.7M
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
IMAX News & Events
Events Timeline
2025-07-24 (ET)
2025-07-24
07:43:32
Imax reports Q2 adjusted EPS 26c, consensus 23c
2025-07-16 (ET)
2025-07-16
18:17:29
Theater chains in talks about how to compete with Imax's screens, Bloomberg says
2025-07-16
09:09:05
IMAX, HOYTS Cinemas relaunch partnership for up to five new laser locations
Sign Up For More Events
Sign Up For More Events
News
9.5
07-25BenzingaPinnedImax Analysts Increase Their Forecasts After Q2 Results
9.5
07-25NASDAQ.COMPinnedIMAX Reports Record Q2 Box Office Surge
9.5
07-24SeekingAlphaPinnedIMAX targets 150–160 system installations in 2025 amid record box office and expanding global footprint
Sign Up For More News
People Also Watch
DEA
Easterly Government Properties Inc
22.860
USD
+0.31%
AMRC
Ameresco Inc
18.120
USD
-3.51%
SAFE
Safehold Inc
14.740
USD
-1.14%
AMWD
American Woodmark Corp
55.900
USD
+0.54%
SPRY
ARS Pharmaceuticals Inc
17.870
USD
-0.28%
SYRE
Spyre Therapeutics Inc
17.790
USD
+1.08%
CBRL
Cracker Barrel Old Country Store Inc
65.780
USD
-1.62%
NMFC
New Mountain Finance Corp
10.590
USD
-0.38%
AOSL
Alpha and Omega Semiconductor Ltd
27.290
USD
-0.69%
IDT
IDT Corp
57.130
USD
-0.49%
FAQ
What is Imax Corp (IMAX) stock price today?
The current price of IMAX is 26.85 USD — it has decreased -5.09 % in the last trading day.
What is Imax Corp (IMAX)'s business?
What is the price predicton of IMAX Stock?
What is Imax Corp (IMAX)'s revenue for the last quarter?
What is Imax Corp (IMAX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Imax Corp (IMAX)'s fundamentals?
How many employees does Imax Corp (IMAX). have?